Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAOIB in Long-COVID Cognitive Impairment
NCT05764538Phase 2Recruiting
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Feb 2023
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of daoib in post-COVID-19 condition (PCC), sponsored by Chang Gung Memorial Hospital. Started Feb 2023; status: recruiting.
02
Drugs
daoib
03
Conditions
post-COVID-19 condition (PCC)
Beyond the preview
Go deeper on NCT05764538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05764538.